Loss of MTSS1 results in increased metastatic potential in pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC) has a 5-year survival rate of 7%. This dismal prognosis is largely due to the inability to diagnose the disease before metastasis occurs. Tumor cell dissemination occurs early in PDAC. While it is known that inflammation facilitates this process, the underlyin...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeleniak, Ann E, Huang, Wei, Brinkman, Mary K, Fishel, Melissa L, Hill, Reginald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369978/
https://www.ncbi.nlm.nih.gov/pubmed/28146435
http://dx.doi.org/10.18632/oncotarget.14869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369978/
https://www.ncbi.nlm.nih.gov/pubmed/28146435
http://dx.doi.org/10.18632/oncotarget.14869

Ejemplares similares